{"name": "NormOxys",
 "permalink": "normoxys",
 "crunchbase_url": "http://www.crunchbase.com/company/normoxys",
 "homepage_url": "http://www.normoxys.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "339-686-7354",
 "description": "",
 "created_at": "Tue May 25 03:36:01 UTC 2010",
 "updated_at": "Tue Nov 22 02:48:14 UTC 2011",
 "overview": "\u003Cp\u003ENormOxys, Inc. operates as a biopharmaceutical company. It provides proprietary products that regulate the binding affinity between oxygen and hemoglobin. NormOxys, Inc. was formerly known as Oxyplus, Inc. and changed its name to NormOxys, Inc. in October 2008. The company was founded in 2003.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       42],
      "assets/images/resized/0008/8364/88364v1-max-150x150.jpg"],
     [[210,
       60],
      "assets/images/resized/0008/8364/88364v1-max-250x250.jpg"],
     [[210,
       60],
      "assets/images/resized/0008/8364/88364v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman",
    "person":
     {"first_name": "Jean-Pierre",
      "last_name": "Garnier",
      "permalink": "jean-pierre-garnier",
      "image":
       {"available_sizes":
         [[[125,
            100],
           "assets/images/resized/0026/7467/267467v1-max-150x150.jpg"],
          [[125,
            100],
           "assets/images/resized/0026/7467/267467v1-max-250x250.jpg"],
          [[125,
            100],
           "assets/images/resized/0026/7467/267467v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Martin",
      "last_name": "Tolar",
      "permalink": "martin-tolar",
      "image": null}},
   {"is_past": false,
    "title": "CSO, Founder",
    "person":
     {"first_name": "Claude",
      "last_name": "Nicolau",
      "permalink": "claude-nicolau",
      "image": null}},
   {"is_past": false,
    "title": "VP, regulatory affairs and program management",
    "person":
     {"first_name": "Gerard",
      "last_name": "Riedel",
      "permalink": "gerard-riedel",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$19.6M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/normoxys-gets-17-5m-fund-poc-work-new-drug-class/2010-05-24?utm_medium=rss\u0026utm_source=rss",
    "source_description": "NormOxys gets $17.5M to fund PoC work on new drug class",
    "raised_amount": 17500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 5,
    "funded_day": 24,
    "investments":
     []},
   {"round_code": "d",
    "source_url": "http://www.masshightech.com/stories/2011/06/20/daily51-NormOxys-finds-15M-in-debt-financing.html",
    "source_description": "NormOxys finds $1.5M in debt financing",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 6,
    "funded_day": 24,
    "investments":
     []},
   {"round_code": "debt_round",
    "source_url": "http://www.masshightech.com/stories/2011/11/21/daily2-NormOxys-lands-600K-financing.html",
    "source_description": "NormOxys lands $600K financing",
    "raised_amount": 600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 11,
    "funded_day": 21,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "16 Laurel Ave.",
    "address2": "Suite 150",
    "zip_code": "02481",
    "city": "Wellesley",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Names new VP Regulatory Affairs",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 5,
    "source_url": "http://www.masshightech.com/stories/2010/10/04/daily24-NormOxys-appoints-Riedel-to-lead-regulatory-affairs.html",
    "source_text": null,
    "source_description": "NormOxys appoints Riedel to lead regulatory affairs",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "NormOxys",
      "permalink": "normoxys"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        79],
       "assets/images/resized/0008/8363/88363v1-max-150x150.jpg"],
      [[250,
        132],
       "assets/images/resized/0008/8363/88363v1-max-250x250.jpg"],
      [[450,
        238],
       "assets/images/resized/0008/8363/88363v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}